J&J agrees to pay drug import fine
Wall Street Journal (subscription required), August 6, 2008
Johnson & Johnson will pay more than $500,000 in fines after the federal government found that the company did not adhere to the Controlled Substances Act when it failed to report the importation of medications.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- House Lawmakers Grill CMS Over Health Exchange Navigators
- ED Physicians Key to Half of Hospital Admissions
- Insurer's App Aims to Lower Healthcare Costs, Securely
- Don't Let Nurses Sink Your Bottom Line
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
